Related Experiment Video
Updated: May 27, 2026

Diffuse Optical Spectroscopy for the Quantitative Assessment of Acute Ionizing Radiation Induced Skin Toxicity Using a Mouse Model
Published on: May 27, 2016
[Skin toxicity]
Atsushi Sato1, Kazuyuki Hamada, Hiromi Imataka
1Dept. of Internal Medicine, Showa University School of Medicine, Tokyo, Japan.
Abstract:
It has been suggested that skin symptoms may cause psychological distress associated with change in appearance, and affect patients' quality of life(QOL). Also, there is a correlation between the severity of skin disorder resulting from treatment with epidermal growth factor receptor(EGFR)inhibitors(cetuximab, panitumumab, erlotinib)and their clinical effects. Treatment with EGFR inhibitors needs to be continued as long as possible while treatment-related skin symptoms are managed appropriately. Adherence to this approach will benefit the patients. Daily self-skin care(keeping the skin surface clean, maintaining moisture retention, and preventing irritation)is the most important countermeasure for hand-foot syndrome resulting from oral administration of fluorinated pyrimidine anticancer drugs(capecitabine, S-1). An early introduction of effective countermeasures including dose reduction/establishment in the rest period is essential for management of such syndrome.
Insights
Managing skin symptoms from cancer treatments like EGFR inhibitors and chemotherapy is crucial for patient quality of life. Appropriate skin care and early intervention improve treatment adherence and outcomes.
Area of Science:
- Oncology
- Dermatology
- Pharmacology
Context:
- Skin toxicities are common side effects of cancer therapies, including epidermal growth factor receptor (EGFR) inhibitors and fluorinated pyrimidines.
- These skin conditions can lead to significant psychological distress, impact appearance, and reduce patients' quality of life (QOL).
- There is a known correlation between the severity of skin disorders and the clinical efficacy of EGFR inhibitors.
Purpose:
- To highlight the importance of managing treatment-related skin symptoms in cancer patients.
- To emphasize the role of proactive skin care and early intervention strategies.
- To underscore the link between effective symptom management and sustained cancer treatment.
Summary:
- Skin symptoms from EGFR inhibitors (cetuximab, panitumumab, erlotinib) are linked to treatment effectiveness and patient QOL.
- Daily self-skin care (cleansing, moisturizing, preventing irritation) is vital for managing hand-foot syndrome from chemotherapy drugs like capecitabine and S-1.
- Early countermeasures, including dose adjustments, are essential for managing these syndromes.
Impact:
- Appropriate management of skin symptoms allows for prolonged treatment with EGFR inhibitors, potentially improving clinical outcomes.
- Effective management of hand-foot syndrome ensures continued oral chemotherapy, benefiting patient prognosis.
- Addressing skin toxicities improves patient QOL and adherence to vital cancer therapies.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Toxic Reactions: Overview
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Drug Toxicity: Overview
Drug Toxicity: Dose-Dependent Reactions
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...